Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K K Fu

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08K K Fu, E Hammond, T F Pajak, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experienceP F Nguyen-Tan, Q T Le, J M Quivey, et al.
Cancer Research|July 15, 1995
Frequent novel DNA copy number increase in squamous cell head and neck tumorsP M Brzoska, N A Levin, K K Fu, et al.
Cancer|May 1, 1996
Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancerJ S Cooper, N C Farnan, S O Asbell, et al.
Genomics|August 15, 1996
Cloning, mapping, and in vivo localization of a human member of the PKCI-1 protein family (PRKCNH1)P M Brzoska, H Chen, N A Levin, et al.
Head & Neck|September 23, 1998
Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?J S Cooper, T F Pajak, A Forastiere, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1990
Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27W R Lee, B Berkey, V Marcial, et al.
Oral Oncology|April 22, 1999
Apoptosis-associated proteins and the development of oral squamous cell carcinomaM L Schoelch, Q T Le, S Silverman, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08K K Fu, E Hammond, T F Pajak, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experienceP F Nguyen-Tan, Q T Le, J M Quivey, et al.
Cancer Research|July 15, 1995
Frequent novel DNA copy number increase in squamous cell head and neck tumorsP M Brzoska, N A Levin, K K Fu, et al.
Cancer|May 1, 1996
Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancerJ S Cooper, N C Farnan, S O Asbell, et al.
Genomics|August 15, 1996
Cloning, mapping, and in vivo localization of a human member of the PKCI-1 protein family (PRKCNH1)P M Brzoska, H Chen, N A Levin, et al.
Head & Neck|September 23, 1998
Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?J S Cooper, T F Pajak, A Forastiere, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1990
Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27W R Lee, B Berkey, V Marcial, et al.
Oral Oncology|April 22, 1999
Apoptosis-associated proteins and the development of oral squamous cell carcinomaM L Schoelch, Q T Le, S Silverman, et al.
Pageof 11